ROQRoquefort TherapeuticsROQ info
$0.04info-4.29%24h
Global rank34216
Market cap$5.71M
Change 7d-
YTD Performance-53.79%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Business data

    Roquefort Therapeutics (ROQ) Stock Overview

    Roquefort Therapeutics plc, a biotechnology company, engages in the development of medicines for the treatment of cancer. The company's pre-clinical development pipeline comprises Midkine antibodies with significance in vivo efficacy and toxicology studies; Midkine RNA therapeutics with novel anti-cancer gene editing action; Midkine mRNA therapeutics with novel anti-cancer approach; STAT-6 siRNA therapeutics targeting solid tumors with significance in vivo efficacy; and MK cell therapy with direct and NK-mediated anti-cancer action. Roquefort Therapeutics plc was incorporated in 2020 and is based in London, the United Kingdom.

    ROQ Stock Information

    Symbol
    ROQ
    Address
    85 Great Portland StreetLondon, W1W 7LTUnited Kingdom
    Founded
    -
    Trading hours
    8:00 AM - 4:30 PM GMT
    Website
    https://www.roquefortinvest.com
    Country
    πŸ‡¬πŸ‡§ United Kingdom
    Phone Number
    44 20 3918 8633

    Roquefort Therapeutics (ROQ) Price Chart

    -
    Value:-

    Roquefort Therapeutics Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.044220336074554174
    N/A
    Market Cap
    $5.71M
    N/A
    Shares Outstanding
    129.15M
    N/A
    Employees
    9.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org